Ms. Dymond's presentation, “Qualification, Monitoring and Challenges in Working with International Suppliers” will take place on August 9, 2011.
Attendees of the talk will gain insights on the unique challenges faced by the pharmaceutical industry when dealing with global suppliers, specifically from within Europe and the U.S. Ms. Dymond will highlight the diverse rules and regulations associated with supply, specifically meeting QP (Qualified Person) requirements, and how to overcome and mitigate the wide-range of risks and varying complexity of obtaining materials and components from international suppliers. Delegates will leaving with a better understanding of common issues faced when working with international suppliers and best practices for overcoming these challenges.
Click here for more information on this conference and to register.
Ms. Dymond, currently based in the UK, provides Catalent with quality and regulatory leadership across the softgel and modified release technology businesses in Europe, Switzerland, Japan, and Australia. Ms. Dymond has over 25 years of pharmaceutical industry experience, where she has developed an extensive understanding of GMP and managerial responsibilites. She has held a variety of global technical and management roles overseeing quality, compliance, validation, and quality control for sterile, biological, solid, softgel and modified release dosage forms.
After studying Microbiology at Bristol West University, Ms. Dymond initially worked as a Bacteriologist/Parasitologist in the UK National Health Service. She then transferred into the pharma industry starting at The Wellcome Foundation, followed by GlaxoSmithKline, Sanofi-Aventis, Schering-Plough/Merck as the Head of Biological Quality in the UK, before joining Catalent in 2010. Ms. Dymond holds an MSc degree in Biomedics from Surrey/Open University and has studied Business Management during her employment.
Attendees of the talk will gain insights on the unique challenges faced by the pharmaceutical industry when dealing with global suppliers, specifically from within Europe and the U.S. Ms. Dymond will highlight the diverse rules and regulations associated with supply, specifically meeting QP (Qualified Person) requirements, and how to overcome and mitigate the wide-range of risks and varying complexity of obtaining materials and components from international suppliers. Delegates will leaving with a better understanding of common issues faced when working with international suppliers and best practices for overcoming these challenges.
Click here for more information on this conference and to register.
Ms. Dymond, currently based in the UK, provides Catalent with quality and regulatory leadership across the softgel and modified release technology businesses in Europe, Switzerland, Japan, and Australia. Ms. Dymond has over 25 years of pharmaceutical industry experience, where she has developed an extensive understanding of GMP and managerial responsibilites. She has held a variety of global technical and management roles overseeing quality, compliance, validation, and quality control for sterile, biological, solid, softgel and modified release dosage forms.
After studying Microbiology at Bristol West University, Ms. Dymond initially worked as a Bacteriologist/Parasitologist in the UK National Health Service. She then transferred into the pharma industry starting at The Wellcome Foundation, followed by GlaxoSmithKline, Sanofi-Aventis, Schering-Plough/Merck as the Head of Biological Quality in the UK, before joining Catalent in 2010. Ms. Dymond holds an MSc degree in Biomedics from Surrey/Open University and has studied Business Management during her employment.
Companies in this article
